- Home
- DNTH vs DMLP Comparison
DNTH vs DMLP Comparison
Compare DNTH & DMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- DMLP
- Stock Information
- Founded
- DNTH 2015
- DMLP 2003
- Country
- DNTH United States
- DMLP United States
- Employees
- DNTH N/A
- DMLP N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- DMLP Oil & Gas Production
- Sector
- DNTH Health Care
- DMLP Energy
- Exchange
- DNTH Nasdaq
- DMLP Nasdaq
- Market Cap
- DNTH 1.0B
- DMLP 1.2B
- IPO Year
- DNTH N/A
- DMLP N/A
- Fundamental
- Price
- DNTH $37.04
- DMLP $25.43
- Analyst Decision
- DNTH Strong Buy
- DMLP
- Analyst Count
- DNTH 9
- DMLP 0
- Target Price
- DNTH $61.57
- DMLP N/A
- AVG Volume (30 Days)
- DNTH 969.3K
- DMLP 96.8K
- Earning Date
- DNTH 11-06-2025
- DMLP 10-30-2025
- Dividend Yield
- DNTH N/A
- DMLP 12.67%
- EPS Growth
- DNTH N/A
- DMLP N/A
- EPS
- DNTH N/A
- DMLP 1.71
- Revenue
- DNTH $4,854,000.00
- DMLP $161,859,000.00
- Revenue This Year
- DNTH N/A
- DMLP N/A
- Revenue Next Year
- DNTH N/A
- DMLP N/A
- P/E Ratio
- DNTH N/A
- DMLP $14.85
- Revenue Growth
- DNTH 17.87
- DMLP 4.04
- 52 Week Low
- DNTH $13.37
- DMLP $24.01
- 52 Week High
- DNTH $38.59
- DMLP $34.88
- Technical
- Relative Strength Index (RSI)
- DNTH 82.86
- DMLP 51.00
- Support Level
- DNTH $36.00
- DMLP $25.31
- Resistance Level
- DNTH $24.81
- DMLP $25.60
- Average True Range (ATR)
- DNTH 2.70
- DMLP 0.46
- MACD
- DNTH 1.31
- DMLP 0.15
- Stochastic Oscillator
- DNTH 90.18
- DMLP 82.09
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.